Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Increase in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 9,100 shares, a growth of 225.0% from the June 15th total of 2,800 shares. Based on an average daily trading volume, of 210,200 shares, the short-interest ratio is currently 0.0 days.

Bioxytran Stock Down 10.5 %

Shares of Bioxytran stock traded down $0.01 during trading on Friday, hitting $0.09. 77,394 shares of the stock traded hands, compared to its average volume of 97,561. Bioxytran has a twelve month low of $0.07 and a twelve month high of $0.35. The company has a fifty day moving average price of $0.11 and a two-hundred day moving average price of $0.12.

Bioxytran Company Profile

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.